2. UroToday Home
  3. Newsletter Archive

GU Onc Weekly

American Society for Radiation Oncology (ASTRO) 2024: Radiotherapy Innovations in GU MalignanciesSent on 30 September 2024
Treatment Strategies for High-Risk Biochemically Recurrent Prostate CancerSent on 28 September 2024
Managing Castrate-Resistant Prostate CancerSent on 27 September 2024
UroAlert - GU Oncology WeeklySent on 26 September 2024
A New Era in the Perioperative Management of Muscle Invasive Bladder CancerSent on 26 September 2024
International Bladder Cancer Group Quarterly Newsletter: Volume 2Sent on 24 September 2024
How to Personalize Therapy in mHSPCSent on 23 September 2024
First Data from the 2024 International Bladder Cancer Network Annual Meeting Sent on 21 September 2024
Highlights from the International Bladder Cancer Network 2024 Annual MeetingSent on 21 September 2024
ESMO 2024: Informing Clinical Practice in Bladder Cancer and Renal CancerSent on 20 September 2024
SPLASH Trial Highlights Radiopharmaceutical Lutetium-177’s Role in Advanced Prostate Cancer Treatment and More on Prostate CancerSent on 19 September 2024
UroAlert - GU Oncology WeeklySent on 19 September 2024
ESMO 2024 Practice Changing Prostate Cancer Trial Results Sent on 17 September 2024
ESMO 2024 Informing GU Cancer TreatmentsSent on 16 September 2024
ESMO 2024 Presidential Symposium II NIAGRA A Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder CancerSent on 16 September 2024
ESMO 2024: SPLASH 177Lu-PNT2002 Improves Radiographic Progression-Free Survival in mCRPC Patients Sent on 15 September 2024
ESMO 2024 Practice Changing Trials - First Results PEACE 3Sent on 14 September 2024
ESMO 2024 Novel Therapeutic Approaches for ARPI-Resistant Disease and Bladder Preservation StrategiesSent on 14 September 2024
European Society of Medical Oncology (ESMO) 2024 - Toni Choueiri Discusses TiNivo-2 Trial Results and More on GU CancersSent on 13 September 2024
UroAlert - GU Oncology WeeklySent on 12 September 2024
PSMA PET Imaging For BCR and Staging of Prostate Cancer Sent on 12 September 2024
European Society for Medical Oncology (ESMO) 2024 Annual Congress Coverage Starts FridaySent on 10 September 2024
Disparities in Bladder Cancer Detection and Treatment Sent on 09 September 2024
When to Do Tumor Genomic Profiling in Advanced Prostate Cancer and What?Sent on 07 September 2024
Antibody-Drug Conjugates in Advanced Urothelial Cancer: Current Landscape and Future DirectionsSent on 06 September 2024
UroAlert - GU Oncology WeeklySent on 05 September 2024
Addressing the Underutilization of Treatment Combinations in Metastatic Castration-Sensitive Prostate Cancer (mHSPC) Sent on 05 September 2024
Comparing PSMA Ligands for Prostate Cancer ImagingSent on 03 September 2024
Advances and Challenges in High-Risk CSPC: A Multidisciplinary Approach to Patient Management Sent on 31 August 2024
UroAlert - GU Oncology WeeklySent on 29 August 2024
The Role of Biomarkers in Prostate Cancer Disease CharacterizationSent on 29 August 2024
Performance of Larger Datasets and Association with Outcomes in Prostate CancerSent on 28 August 2024
PSMA PET and Radioligand Therapy in 2024 - The Treatment Landscape in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Sent on 27 August 2024
New and Noteworthy - Bladder Cancer and Renal Cancer 2024 Sent on 26 August 2024
Cutting-Edge Innovations in Urologic Robotics and Precision Surgery from the 2024 WCETSent on 24 August 2024
New Targets and Treatments in Development for mCRPCSent on 23 August 2024
UroAlert - GU Oncology WeeklySent on 22 August 2024
Imaging and Treatment Strategies in Biochemical Recurrence in Prostate CancerSent on 22 August 2024
World Congress of Endourology and Uro-Technology (WCET) 2024: Leave No Stone Unmeasured - Predicting Outcomes, and Innovations in UreteroscopySent on 21 August 2024
Tailoring Treatment and Navigating Patient Preferences in Bladder Cancer Sent on 20 August 2024
World Congress of Endourology and Uro-Technology (WCET) 2024: Advancements in Robotic-Assisted Urology Sent on 19 August 2024
PSMA Radioligand Therapy in Patients with Prostate CancerSent on 17 August 2024
UroAlert - GU Oncology WeeklySent on 15 August 2024
Timing and Rationale for Repeat TURBT: Perspectives on Improving Bladder Cancer OutcomesSent on 15 August 2024
Strategies and Therapeutic Advances in Metastatic Prostate Cancer Sent on 14 August 2024
New Targets in the Treatment of Metastatic Prostate CancerSent on 13 August 2024
Managing High-Risk Recurrent Prostate CancerSent on 12 August 2024
Bladder Cancer Advocacy Network (BCAN) Think Tank 2024 - Novel Treatment StrategiesSent on 11 August 2024
Bladder Cancer Advocacy Network (BCAN) Think Tank - Bridging Evidence Generation to Practice in Bladder Cancer CareSent on 10 August 2024
Precision-Based Genomics in Prostate CancerSent on 09 August 2024
  • Page of 48
Display #
Results 1 - 50 out of 2352
Send the selected Newsletters to...